Erratum to cancer cachexia syndrome and clinical outcome in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: results from a prospective, observational study

Erratum to: Transl Lung Cancer Res 2021;10:3538-49

This article (1) titled “Cancer cachexia syndrome and clinical outcome in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: results from a prospective, observational study” (doi: 10.21037/tlcr-21-460), unfortunately contains errors in the authorship section.

The current affiliation 5 should be added under the names Konstantinos Rounis, Alexia Monastirioti, Dimitrios Mavroudis, and Sofia Agelaki.

In order to keep all affiliations appearing consecutively, the current affiliation 5 should be listed as affiliation 2. Following this change, the current affiliations 2–4 should be updated as affiliations 3–5. Affiliations 1 and 6 remain the same. Moreover, as Konstantinos Rounis is the corresponding author of this article, the correspondence information should be updated as well. The updated authorship section is presented below.

The authorship section should be updated as follows

Konstantinos Rounis^1,2^, Dimitrios Makrakis³, Alexandros-Pantelis Tsigkas⁴, Alexandra Georgiou⁴, Nikolaos Galanakis⁵, Chara Papadaki², Alexia Monastirioti², Lambros Vamvakas¹, Konstantinos Kalbakis¹, Nikolaos Vardakis¹, Meropi Kontogianni⁴, Ioannis Gioulbasanis⁶, Dimitrios Mavroudis^1,2, Sofia Agelaki^1,2

¹Department of Medical Oncology, University General Hospital of Heraklion, Heraklion, Greece; ²Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Greece; ³Division of Oncology, University of Washington Medical School, Seattle, WA, USA; ⁴Department of Nutrition & Dietetics, School of Health Sciences and Education, Harokopio University, Athens, Greece; ⁵Department of Medical Imaging, University General Hospital, Heraklion, Greece; ⁶Department of Medical Oncology, Animus Kyanus Stavros General Clinic, Larissa, Greece

Correspondence to: Konstantinos Rounis, MD. Department of Medical Oncology, University General Hospital of Heraklion, Leoforos Panepistimiou, Iraklio 715 00, Heraklion, Greece; Laboratory of Translational Oncology, School of Medicine, University of Crete, Andrea Kalokerinou 13, Giofirakia 715 00, Heraklion, Greece. Email: kostas@rounis.gr.

The authors apologize for the oversight.

Click here to view the updated version of the article.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

References

1. Rounis K, Makrakis D, Tsigkas AP, et al. Cancer cachexia syndrome and clinical outcome in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: results from a prospective, observational study. Transl Lung Cancer Res 2021;10:3538-49. [Crossref] [PubMed]